Eli Lilly and Company LLY is one of the two clear leaders in the rapidly expanding diabetes and obesity treatment market, ...

The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.

New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, ...

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 13 hot stocks to buy with the highest upside potential. On February 5, BofA initiated coverage of Wave Life Sciences Ltd. (NASDAQ:WVE) with a Buy ...

HARTFORD, Conn. (WTNH) — Obesity affects millions of Americans and is now recognized as a chronic disease that requires ...

Experts at a roundtable in Boston, Massachusetts, on November 19, 2025, discussed multidisciplinary strategies for obesity ...

Researchers are applying insights into the genetic variations and physiology of obesity to apply tailored interventions to ...

As obesity rates continue to rise, many are turning to prescription medicines like Ozempic for weight loss. But with significant side effects, accessibility and cost issues, alternatives are needed.

Domestically developed obesity drugs are expected to enter the market within this year. Major companies, including Hanmi ...

In every single state, researchers expect at least 35% of adults to have a body mass index of 30 or higher, the threshold ...

Many have declared drugs like Ozempic could "end obesity" by reducing the appetite and waistlines of millions of people around the world. When we look past the hype, this isn't just untrue—it can also ...

Sen. Ana Maria Rodriguez and Rep. Susan L. Valdés were joined Thursday by Dr. Joey Jarrard of Tallahassee Memorial Healthcare ...